Baron and Budd Investigates Claims for NaturaLyte and GranuFlo Lawsuits

  Baron and Budd Investigates Claims for NaturaLyte and GranuFlo Lawsuits

  Serious health risks alleged with NaturaLyte, a sister product of GranuFlo

Business Wire

ST. LOUIS -- August 29, 2013

As part of the growing GranuFlo lawsuit, the national law firm of Baron and
Budd is investigating NaturaLyte, a lesser known but potentially harmful
dialysate also manufactured by Fresenius Medical Care.

Both NaturaLyte and GranuFlo are alleged to increase a patient’s risk of heart
attack. While GranuFlo comes in a powder acid concentrate, NaturaLyte is
manufactured as a liquid acid concentrate. Both liquid and powder forms
allegedly increase the levels of bicarbonate in the blood, in turn increasing
the risk of heart attack if additional doses of bicarbonate prescriptions are
not adjusted.

Dialysis is a long-term medical treatment used to manage kidney conditions.
Dialysates - such as GranuFlo and NaturaLyte - are the liquids used to filter
a patient's blood during dialysis.

"The manufacturers of GranuFlo and NaturaLyte should have warned users about
the serious heart attacks risks associated with their products as soon as they
were made aware,” said Russell Budd of Baron and Budd. “Had doctors and
patients been more aware of these risks, lives could have been saved."

Over 400,000 Americans currently undergo dialysis treatments. More than
one-third of these patients receive their dialysis care with Fresenius, the
world's largest manufacturer of dialysis products and services.

Please contact the Baron and Budd GranuFlo lawsuit lawyers at 1.866.844.4556
or info@baronbudd.com if you or someone you know has experienced a heart
attack after receiving dialysis. For more information about our GranuFlo
lawsuit lawyers, visit Baron and Budd’s website at
http://baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/.

Baron and Budd is a nationally recognized law firm with a strong track record
of success "Protecting What's Right" for individuals, businesses and
communities. Firm shareholder Burton LeBlanc was recently appointed to the
attorney leadership committee that oversees all activity in the
GranuFlo/NaturaLyte litigation. The lawyers at Baron and Budd were also
recently involved with litigation surrounding the diabetes drug Avandia. Baron
and Budd represented over 7,000 people who were harmed by Avandia.

About Baron & Budd, P.C.

The law firm of Baron & Budd, P.C., with offices in Dallas, Baton Rouge,
Austin and Los Angeles, is a nationally recognized law firm with a 35-year
history of "Protecting What's Right" for people, communities and businesses
harmed by negligence. Baron & Budd's size and resources enable the firm to
take on large and complex cases. The firm represents individuals, governmental
and business entities in areas as diverse as water contamination, Gulf oil
spill, Qui Tam, California Proposition 65 violations, dangerous medications
and medical devices, Chinese drywall, insurance claims, consumer fraud,
securities fraud and asbestos-related illnesses such as mesothelioma.

Contact:

Baron & Budd
Susan Knape, 214-629-0596
susan@susanknape.com
or
Amanda Billo, 214-991-1051
abillo@baronbudd.com